Source:http://linkedlifedata.com/resource/pubmed/id/20665748
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
2010-12-1
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
2151-4658
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
62
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1679-81
|
| pubmed:dateRevised |
2011-5-5
|
| pubmed:meshHeading |
pubmed-meshheading:20665748-Adult,
pubmed-meshheading:20665748-Dose-Response Relationship, Drug,
pubmed-meshheading:20665748-Glucocorticoids,
pubmed-meshheading:20665748-Humans,
pubmed-meshheading:20665748-Immunosuppressive Agents,
pubmed-meshheading:20665748-Morbidity,
pubmed-meshheading:20665748-Survival Rate,
pubmed-meshheading:20665748-Systemic Vasculitis,
pubmed-meshheading:20665748-Treatment Outcome
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
The downsides of a major medical advance.
|
| pubmed:publicationType |
Editorial
|